Should You Buy Afren Plc As Shares Surge Higher On Bid Hopes?

Buying Afren Plc (LON:AFR) shares on bid hopes could be a mistake, as Roland Head explains.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Afren (LSE: AFR) shares rose by more than 50% in the first half hour of trading this morning, leaving them around 65% higher than when markets opened on Friday.

Afren’s gains on Friday came after the firm revealed that that the UK Takeover Panel had agreed to allow bid talks with Seplat to be extended until 13 February.

However, this morning’s gains may also have been driven by a second statement issued by Afren, late on Friday evening, after markets had closed. In this statement, Afren confirmed it had agreed with its lenders to delay $65m of interest payments until the end of February.

Should you be buying — or is this a good chance to sell, before it’s too late?

The smart money is out

Big institutional investors are often criticised by private investors for their high fees and average results, but they do tend to have a good understanding of financial analysis and risk.

Two of Afren’s biggest institutional investors — Standard Life and SKAGEN Funds — have sold 107m shares in Afren since November. That’s equivalent to nearly 10% of the oil firm’s shares.

Who has bought those shares? We don’t know, but if any shareholders had increased their stakes above 3%, then Afren would have had to disclose this. This hasn’t happened, suggesting to me that smaller investors have picked up the shares in the hope of a rebound.

The harsh reality

Ultimately, Friday’s statements didn’t change anything: Afren still has no cash and is now effectively in arrears to the tune of $65m on debt interest payments, which have simply been delayed for a month.

It’s important to remember that debt repayments always take priority over shareholder rights: Afren is now effectively controlled by its lenders, and any solution to the current situation is likely, at best, to involve shareholders being heavily diluted.

Seplat may yet make a bid, but any offer is unlikely to be at a premium to the current share price, as there’s no need for this. Realistically, all Seplat would have to do to take control of Afren is to agree to take responsibility for Afren’s debt and funding obligations and perhaps make a nominal offer — below today’s share price — for the shares.

Shareholders would have no choice but to accept, because Afren’s lenders would withdraw their support if the offer was not accepted, leaving Afren in administration.

In my view, buying Afren shares in today’s market is complete speculation and very high risk: even in the troubled oil market, there are far better buys available elsewhere.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Roland Head has no position in any shares mentioned. The Motley Fool UK has recommended Afren. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »